A granted patent with a problem leaves its owner with two post-grant tools: patent reissue to correct errors or recover claim scope, or ex parte reexamination to challenge the patent’s validity against prior art. Those are not variations of the same tool. They answer different problems, they run through different units at the USPTO, and choosing the wrong one costs time, money, and sometimes the patent itself.
The diagnostic question that separates them is direct: is the problem with the patent yours to fix, or is prior art the issue? If you drafted claims too narrowly, missed dependent claims, or need to correct a specification error, reissue is the right path. If prior art surfaced after grant — whether you found it or a third party is threatening to use it — reexamination is what the statute was built for. Under 35 U.S.C. 251, reissue requires admitting an error in the original patent; under 35 U.S.C. 302, reexamination requires identifying a substantial new question of patentability based on prior art.
Last updated: June 2026
The core difference: error correction vs prior art challenge
Reissue operates under 35 U.S.C. 251, which permits a patent owner to surrender a granted patent and receive a new one correcting errors made “without any deceptive intention.” The errors that qualify include claims that are too narrow or too broad, missing dependent claims, incorrect inventorship, and specification problems that affect claim support. The key point: reissue is initiated by the patent owner and requires admitting that something went wrong in the original prosecution.
Ex parte reexamination operates under 35 U.S.C. 302, which allows any person, at any time during a patent’s enforceability period, to ask the USPTO to reconsider the patent’s claims against prior art. The request must raise a “substantial new question of patentability” based on prior patents or printed publications. Prior art is both the trigger and the boundary: reexamination cannot fix specification errors, add claims for unclaimed embodiments, or correct inventorship. It can only address whether the existing claims hold up against art the original examiner did not consider.
This distinction has a direct procedural consequence. In reissue, the patent owner is conducting what amounts to a new prosecution, with all the options that entails.
In reexamination, even if the patent owner filed the request themselves, the proceedings are narrower, the appeal path is more constrained, and there is no way to stop the process once it starts.
When reissue is the right path
Reissue prosecution fits when the patent owner identifies a problem that is internal to the patent, not driven by newly discovered prior art. The most common scenarios:
Claims that are too narrow. A broadening reissue allows a patent owner to pursue claims with wider scope than the original prosecution produced. This is the most strategically valuable use of reissue, and it comes with a firm deadline: a broadening reissue application must be filed within two years of the original grant date. Miss that window, and the option is gone permanently. A narrowing reissue, by contrast, can be filed at any point before the patent expires.
Missing dependent claims. Under the Federal Circuit’s decision in In re Tanaka, adding narrower dependent claims that were inadvertently omitted from the original application qualifies as the kind of “error” that reissue is designed to correct. This is a lower-risk use of the process because it does not expand claim scope.
Specification errors that undermine claim support. If the written description has gaps or inaccuracies that create vulnerability in enforcement, reissue allows the owner to address those before a validity challenge surfaces in litigation.
Incorrect inventorship. A reissue application can correct inventorship when the original application named the wrong inventors or omitted someone who contributed to the conception of the invention.
What reissue cannot do: it cannot cure inequitable conduct, and it is not a second chance to prosecute the original application from scratch. The reissue statute is specific that the correction must address a genuine error, not a strategic reconsideration.
One important procedural point that most attorneys don’t emphasize: a reissue application can be abandoned if the proceedings go badly, and the original patent survives with its original claims intact. That safety valve does not exist in reexamination.
When reexamination is the right path
Ex parte reexamination fits when prior art is the source of the problem or the anticipated threat.
Prior art found after grant. If a patent owner discovers prior art that a competitor might use to challenge validity, filing a reexamination request proactively can address the issue before litigation. The proceeding gives the patent owner an opportunity to amend claims or argue around the newly discovered reference under USPTO procedures rather than in federal court.
Preempting a third-party challenge. Because anyone can file a reexamination request, a patent owner who gets ahead of a likely challenge controls the timing. The USPTO’s Central Reexamination Unit processes these with special dispatch, particularly when concurrent litigation is pending.
Third-party validity challenges. A third party who wants to challenge a patent without the cost and exposure of inter partes review can file an anonymous ex parte reexamination request. The USPTO issued updated guidance on this in February 2026, clarifying the requirements for anonymous requests. Once the request is granted, the third party has no further participation in the proceeding, but the patent owner must respond to each office action the CRU issues.
One strategic context worth noting: reexamination filings accelerated sharply in late 2025, reaching roughly 95 to 115 per month by November-December 2025, compared to 20 to 55 per month earlier that year. Much of that increase reflects practitioners treating reexamination as a substitute when inter partes review has become harder to access. That shift in usage patterns affects how examiners in the CRU are seeing these cases and the volume of work they are managing.
Key differences at a glance
| Patent reissue | Ex parte reexamination | |
|---|---|---|
| Who can file | Patent owner only | Any person |
| Purpose | Correct errors in the patent | Challenge validity against prior art |
| Scope of review | Full prosecution (errors, claims, spec) | Prior art only (patents, printed publications) |
| Broadening allowed | Yes, within 2 years of grant | No |
| Can add new claims | Yes | Only to narrow existing claims |
| Abandonment option | Yes, original patent survives | No, cannot be stopped once ordered |
| RCE available | Yes | No (only appeal after Final Action) |
| Result | New reissued patent | Reexamination certificate on original patent |
| IPR estoppel (315(b) bar) | Does not apply to reissued patent | Applies to reexamined patent |
| USPTO filing fee (large entity) | $350 basic + $770 search + $800 exam | $6,300 (streamlined, 40 pages or fewer) |
| Typical timeline | 18-30 months | 12-24 months |
USPTO fees are current as of the fee schedule effective January 19, 2025, last revised May 1, 2026. Source: USPTO fee schedule. Additional fees apply for claims in excess of three independent claims or 20 total claims.
Strategic considerations from the examiner’s side
The examiner structure at the USPTO is different for reissue and reexamination cases, and those differences matter more than most practitioners acknowledge.
Reissue applications go to the Central Reexamination/Reissue Unit, where a team of three specialized examiners reviews the application rather than a single examiner under production pressure. These examiners are experienced and are not subject to the count-driven incentives that govern standard prosecution. They approach a reissue with the posture that if the patent is back before the office, something went wrong. Expect a thorough prior art search and additional rejection types that do not appear in standard prosecution, including recapture rejections, original invention rejections, and, if filed more than two years after grant, broadening rejections. Amendment practice in reissue is materially more complex than in original prosecution, and the examiner knows that.
Reexamination, by contrast, is bounded: the CRU can only apply prior art rejections under 35 U.S.C. 102 and 103. The examiner cannot reject claims on written description grounds, enablement, or other non-prior-art bases. That boundary is a genuine strategic advantage when claim scope is solid and the issue is purely about what the original examiner considered.
The appeal path difference is worth understanding before choosing. In a reissue, after a Final Office Action, the patent owner can file a Request for Continued Examination and keep prosecuting. In reexamination, per MPEP 2215, that option does not exist. After a Final Action in reexamination, the only path forward is appeal to the Patent Trial and Appeal Board, then to the Federal Circuit if needed. If the claims worth preserving are borderline against the cited art, the absence of an RCE option is a meaningful constraint.
The IPR estoppel distinction also matters if litigation is in the picture. A reissued patent is a new patent, and the 35 U.S.C. 315(b) bar that applies when a complaint alleging infringement has been served does not attach to it in the same way it attaches to the original. A reexamined patent remains the original patent, and that bar follows it. For patents that are or might become the subject of infringement litigation, the distinction between receiving a reissue certificate and a reexamination certificate has real consequences.
Our team at IP Boutique Law evaluates both paths with the CRU’s current posture in mind, not just the statutory requirements. The right choice depends on the specific claims at issue, the prosecution history, and whether litigation risk is already present.
Cost and timeline comparison
Attorney fees for both proceedings vary with complexity, number of claims, and whether multiple rounds of office actions are needed. As a baseline:
Reissue prosecution at IP Boutique Law runs $5,000 to $10,000 for prosecution through allowance. That range covers application preparation, office action responses, and proceedings through the CRU. USPTO filing fees for a reissue application are $350 (basic filing), $770 (search fee), and $800 (examination fee) for large entities, with 50% and 75% reductions for small and micro entities respectively, per the current USPTO fee schedule.
Ex parte reexamination has two distinct cost components. The request itself — which requires making the strongest prior art argument before the CRU rules on whether to order the proceeding — runs $15,000 to $50,000 in attorney fees. That front-loaded cost reflects the fact that the requester gets one shot to frame the issue. Once ordered, prosecution of the reexamination runs $10,000 to $30,000. The USPTO filing fee for a streamlined request of 40 pages or fewer is $6,300 for large entities, $2,520 for small entities, and $1,260 for micro entities, per MPEP 2215.
Timeline: reissue proceedings typically run 18 to 30 months from filing to issuance of the reissued patent. Reexamination, which the USPTO is required to handle with “special dispatch,” tends to close in 12 to 24 months, faster when concurrent litigation creates additional urgency.
When to pursue each option
Reissue makes sense when:
- You have a granted patent with claims narrower than the disclosed invention supports
- You want to add dependent claims that were inadvertently omitted
- You have a broadening reissue opportunity and are within the two-year window
- The specification has support problems that could be exploited in enforcement
- Inventorship needs to be corrected
Reexamination makes sense when:
- Prior art relevant to the patent’s claims surfaced after grant
- You want to proactively address a validity risk before litigation
- A third party is threatening to challenge the patent and you want to control timing
- The issue is entirely about what the original examiner considered, not about claim scope or specification adequacy
The two are not mutually exclusive. Patents facing both internal claim problems and prior art exposure sometimes benefit from running a reissue to strengthen claims while separately addressing prior art through a reexamination request. That level of strategy depends on a close reading of the prosecution history and the current competitive landscape for the invention. If you’re trying to determine which path applies to your patent, starting with a patent prosecution review of the original file history clarifies what errors exist and whether prior art is the real threat.
FAQs
Reissue under 35 U.S.C. 251 lets a patent owner correct internal errors, including claims that are too narrow or too broad, missing dependent claims, and specification problems. Reexamination under 35 U.S.C. 302 is limited to challenging claim validity against prior art. Reissue requires admitting an error; reexamination requires identifying a substantial new question of patentability based on patents or printed publications.
No. Ex parte reexamination is limited to prior art rejections and cannot be used to broaden claim scope. Only a reissue application allows claim broadening, and only if filed within two years of the original patent grant date. After that two-year window closes, a reissue application can still narrow claims or correct other errors but cannot expand protection beyond what was originally granted.
Patent reissue proceedings typically take 18 to 30 months from filing to issuance of the reissued patent. Reissue applications go to the USPTO’s Central Reexamination/Reissue Unit, where a panel of three specialized examiners handles prosecution. The timeline depends on the number of office actions, claim complexity, and whether amendments require multiple rounds of examination.
Any person can file an ex parte reexamination request at any point during a patent’s enforceability period, including third parties, the patent owner, or an anonymous requester. The USPTO issued updated guidance in February 2026 on the requirements for anonymous requests. Once the USPTO orders the reexamination, the third-party requester has no further participation in the proceedings.
A broadening reissue application, one that seeks claims with wider scope than the original patent, must be filed within two years of the original grant date. After that deadline, the patent owner can still file a narrowing reissue to correct specification problems, adjust claim scope downward, or add dependent claims, but the option to broaden protection is permanently closed.
Yes. If the USPTO determines during reexamination that the prior art raises a substantial new question of patentability and the patent owner cannot distinguish the claims through argument or amendment, the examiner can confirm cancellation of any or all claims at issue. The result is a reexamination certificate that reflects whatever claims survived, which may be a narrowed set, no independent claims, or in the worst case, all claims canceled.
IP Boutique Law is a patent and intellectual property firm in Washington, D.C. with 25+ years of USPTO examiner experience. Our team handles patent drafting, prosecution, trademark registration, design patents, provisional applications, ex parte reexamination, and patent reissue across chemical, biochemical, electrical, and mechanical fields. We serve inventors and companies in the U.S. and internationally, bringing insider examiner knowledge to every stage of the patent process.
Reviewed by Carlos López, patent attorney and former USPTO examiner with 25+ years of IP experience.